Investing
Investing Cash Flow
AbbVie Investing Cash Flow increased by 60.8% to -$574.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.9%, from -$735.00M to -$574.00M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 41.5% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 8, 2026
How to read this metric
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
Detailed definition
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Peer comparison
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
Metric ID:
net_cash_from_investingHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$242.00M | -$615.00M | -$1.15B | -$1.59B | -$448.00M | -$499.00M | -$341.00M | -$369.00M | -$800.00M | -$9.59B | -$1.10B | -$8.26B | -$1.87B | -$735.00M | -$1.18B | -$3.26B | -$1.46B | -$574.00M |
| QoQ Change | — | -154.1% | -86.2% | -39.0% | +71.8% | -11.4% | +31.7% | -8.2% | -116.8% | <-999% | +88.5% | -649.2% | +77.3% | +60.8% | -60.7% | -176.4% | +55.2% | +60.8% |
| YoY Change | — | — | — | — | +60.9% | +68.6% | — | — | -78.6% | <-999% | -223.2% | <-999% | -134.3% | +92.3% | -7.2% | +60.5% | +21.9% | +21.9% |
Range-$9.59B – -$242.00M
CAGR+22.5%
Avg YoY Growth-339.7%
Median YoY Growth+7.4%
Current Streak2 quarters growth
Investing Cash Flow at Other Companies
Frequently Asked Questions
- What is AbbVie's investing cash flow?
- AbbVie (ABBV) reported investing cash flow of -$574.00M in Q1 2026.
- How has AbbVie's investing cash flow changed year-over-year?
- AbbVie's investing cash flow increased by 21.9% year-over-year, from -$735.00M to -$574.00M.
- What is the long-term trend for AbbVie's investing cash flow?
- Over 3 years (2021 to 2025), AbbVie's investing cash flow has grown at a 41.5% compound annual growth rate (CAGR), from -$2.34B to -$6.64B.
- What does investing cash flow mean?
- The net amount of cash spent on or received from investing activities.